News
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...
A new study has made the case for synching your daily calories with your own circadian rhythm to improve glucose metabolism, ...
Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein intake may help prevent muscle loss in these patients, according to a small ...
22hon MSN
Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...
For many people, weight loss is often framed as a matter of willpower – a simple equation of exercising regularly and eating a healthy diet. But, Dr. Sindhura Bandaru, an ...
An oral melanocortin-4 receptor agonist conferred significant BMI reductions among adolescents and adults with hypothalamic ...
Explore more
Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...
This segment is sponsored by Eli Lilly and Company.Social media is flooded with advertisments for popular obestiy medications ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.
For years, people living with obesity have been given the same basic advice: eat less, move more. But while this mantra may ...
Obesity isn’t just a global problem - it’s hitting Singapore hard. In 2022, nearly 12 out of every 100 adults were obese - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results